Pages

▼
Tuesday, August 18, 2026

REMS Removed: Why CAR-T’s Expansion into Community Oncology Could Benefit the Big Three Wholesalers

›
By Greis Kapexhiu and Adam J. Fein, Ph.D. In June 2025, the FDA announced that CAR-T therapies would no longer be subject to a REMS progr...
Friday, August 14, 2026

Hub Transitions Need Proven Plans, Smart Scale-Up

›
Today's guest post comes from Josh Marsh, Vice President and General Manager at Cardinal Health Sonexus™ Access and Patient Support....
Tuesday, August 11, 2026

The K-Shaped Pharmacy Shakeout: Consolidation in Cities, Lost Access in Rural America

›
By Bryce Platt, PharmD The United States has almost 8,000 fewer retail pharmacies than it did in 2018, and more than 2,000 closed in 2025 ...
Monday, August 10, 2026

Informa Connect’s Medicaid Drug Rebate Program Summit

›
Informa Connect’s Medicaid Drug Rebate Program Summit October 5-7, 2026 | Chicago, IL Drug Channels readers save 10% with code 26DRCH10* ...
Friday, August 07, 2026

A System of Record, or a System of Learning?

›
Today's guest post comes from Scott Filosi, Chief Commercial Officer at Valeris. Scott explores how patient access organizations ...
Tuesday, August 04, 2026

Who Will Pay for Prescription Drugs in 2034? Medicare's Surprising Rise in the Latest Government Forecasts

›
By Adam J. Fein, Ph.D. and Greis Kapexhiu In late June, the boffins at the Centers for Medicare & Medicaid Services (CMS) released the...
Friday, July 31, 2026

The Industry Doesn't Have an Access Collaboration Problem. It Has an Accountability Problem.

›
Today's guest post comes from Jen Norton, President, Market Access & Value at EVERSANA. Jen examines why fragmented ownership ...
Tuesday, July 28, 2026

Drug Channels News Roundup, Mid-July 2026: Biosimilar Launch Strategy, Part D Spending Trends, Rural 340B Hospitals, What Employers Can Do About 340B, and Drug Channel Villains

›
By Bryce Platt, PharmD Summer's in full swing, but the drug channel didn't take a break. What better way to spend the summer than...
Friday, July 24, 2026

Direct-to-Patient: Transforming the Manufacturer Access Model

›
Today's guest post comes from Chip Parkinson, CEO at Gifthealth. Chip discusses how Direct-to-Patient (DTP) models can transform th...
Tuesday, July 21, 2026

2025 Gross-to-Net Realities at Eight Top Drugmakers: The Net Pricing Drug Channel Emerges

›
By Adam J. Fein, Ph.D. Every year, Drug Channels reviews drug pricing trends at the largest pharmaceutical manufacturers. This year's...
Friday, July 17, 2026

Direct-to-Consumer Shouldn't Always Mean Direct-To-Mail-Order: Why Fulfillment Choice Matters

›
Today's guest post comes from Divya Iyer, SVP, Head of Revenue, Pharma Direct at GoodRx. Divya examines why direct-to-consumer strat...
Wednesday, July 15, 2026

The 340B Program Hit $100 Billion in 2025: Has It Become Too Big to Reform?

›
By Adam J. Fein, Ph.D. The 340B Drug Pricing Program continues to redefine the meaning of "skyrocketing." For 2025, discounted pu...